John Chung-Kai Chan, M.D. , Scientist; Gynecologic Oncologist at CPMC

California Pacific CURRENTS: The online journal of CPMC Research Institute

New advances in the treatment of gynecologic cancers

Research Overview

  • Dr. Chan specializes in the surgical and medical treatment of ovarian and other pelvic cancers at CPMC. He is board certified in gynecologic oncology, and obstetrics and gynecology.
  • He is investigating new treatments for gynecologic cancers, including targeted biologic therapies, and exploring the role of tumor-initiating cells in ovarian cancer.
  • A clinician and surgeon, Dr. Chan is a principal investigator of studies assessing the treatment and health outcomes of ovarian and uterine cancer patients.
  • Dr. Chan is the Gynecologic Oncology Lead for the Sutter Cancer Research Consortium.
  • He is a Physician Lead in CPMCRI’s Cancer Avatar Project.

Listen to Dr. Chan's perspectives on gynecologic cancer care at Sutter Health.


Training


Dr. Chan obtained his M.D. from Los Angeles School of Medicine in Los Angeles, California. While at the University of California at Irvine, he completed a residency in obstetrics and gynecology, and a fellowship in gynecologic oncology.


 

Publication Search

Publications

Tarney CM, Tian C, Wang G, Dubil EA, Bateman NW, Chan JK, Elshaikh MA, Cote ML, Schildkraut JM, Shriver CD, Conrads TP, Hamilton CA, Maxwell GL, Darcy KM, Impact of age at diagnosis on racial disparities in endometrial cancer patients. Gynecol Oncol

Chan JK, Deng W, Higgins RV, Tewari KS, Bonebrake AJ, Hicks M, Gaillard S, Ramirez PT, Chafe W, Monk BJ, Aghajanian C, A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol

El-Naggar AK, Chan JKC, Takata T, Grandis JR, Slootweg PJ, The fourth edition of the head and neck World Health Organization blue book: editors' perspectives. Hum Pathol

VIEW ALL
John Chung-Kai Chan, M.D. , Scientist; Gynecologic Oncologist at CPMC
Primary Research Interests
  • Diagnosis and treatment of ovarian and pelvic cancers
  • Prognostic factors for high-risk, early stage epithelial ovarian cancer